Most Squamous Cell Carcinomas are Found in the Head and Neck Region.

Published Date: 27 Apr 2023

According to recent data on Medicare beneficiaries in the US, squamous cell carcinomas are more frequently found in the head and neck region of the body than in other places.

Read Full News

Latest News

Upadacitinib Switch from Dupilumab Effective in Head and Neck Atopic Dermatitis

Updated Urticaria Guidelines Clarify Diagnosis, Biomarkers, Treatment Pathways

6 Dermatology Headlines You Missed in January 2026

Bimekizumab Demonstrates Long Term Efficacy in Hidradenitis Suppurativa

Expert Consensus on Knowledge Gaps in Dermatology for Skin of Color, With Henry Lim, MD Henry Lim, MD

This interview with Lim highlights knowledge gaps examined by an international expert panel reviewing existing literature on dermatologic disease in skin of color.

Upadacitinib Regulatory Applications Submitted for Adults, Adolescents with Vitiligo

Todays Updates

Phase 3b RESHAPE Study Evaluates Risk–Benefit of Switching From Ocrelizumab to BTK Inhibitor Remibrutinib Isabella Ciccone, MPH

A phase 3b study presented at ACTRIMS 2026 is evaluating whether switching to remibrutinib offers efficacy and safety comparable to continued ocrelizumab treatment in relapsing multiple sclerosis.

Todays Updates

Phase 3b RESHAPE Study Evaluates Risk–Benefit of Switching From Ocrelizumab to BTK Inhibitor Remibrutinib Isabella Ciccone, MPH

A phase 3b study presented at ACTRIMS 2026 is evaluating whether switching to remibrutinib offers efficacy and safety comparable to continued ocrelizumab treatment in relapsing multiple sclerosis.

Latest News

Upadacitinib Switch from Dupilumab Effective in Head and Neck Atopic Dermatitis

Updated Urticaria Guidelines Clarify Diagnosis, Biomarkers, Treatment Pathways

6 Dermatology Headlines You Missed in January 2026

Bimekizumab Demonstrates Long Term Efficacy in Hidradenitis Suppurativa

This interview with Lim highlights knowledge gaps examined by an international expert panel reviewing existing literature on dermatologic disease in skin of color.

Upadacitinib Regulatory Applications Submitted for Adults, Adolescents with Vitiligo

News All Time

Practical Approaches to Hyperpigmentation and Hypopigmentation, With Nada Elbuluk, MD, MSc, and Michelle Rodrigues, MBBS Nada Elbuluk, MD, MSc, Michelle Rodrigues, MBBS

This segment of the latest Skin of Color Savvy episode highlights a conversation between Nada Elbuluk, MD, MSc, and Michelle Rodrigues, MBBS.

Skin of Color Savvy: Highlights from 2025 Tim Smith

In this end-of-year reel, HCPLive has showcased several key highlights from the Skin of Color Savvy podcast in 2025.

Skin of Color Savvy: On-Site Interviews at the Meeting the Challenge Summit Angel S. Byrd, MD, PhD, Valerie D. Callender, MD, Valerie Harvey, MD, MPH, Stafford Brown, MD, MBA

This episode of Skin of Color Savvy was filmed on-site at the Skin of Color Society's 'Meeting the Challenge Summit' in Washington, DC.

Skin of Color Savvy: Highlights From the Most-Watched Episodes of 2025 Andrew F Alexis, MD, MPH, Shawn Kwatra, MD, Crystal Aguh, MD, FAAD, John E. Harris, MD, PhD, Nada Elbuluk, MD, MSc, Michelle Rodrigues, MBBS

This new episode from January 2026 features a compilation of 3 clips from the most viewed episodes of 2025.

Maui Derm 2026 Presentation Highlights Icotrokinra, Other New Dermatology Drugs

The HCPFive: Top News for Healthcare Providers from the Week of 01/18

Amlitelimab Effective, Safe for Atopic Dermatitis in Patients 12 Years and Older

LEVEL UP: New Data on Switching from Dupilumab to Upadacitinib in Atopic Dermatitis

Personalized Care Improvements Identified for Older Patients with Skin Cancer

What to Expect at the 2026 Maui Derm Conference

New Findings on Acne Incidence in Transgender Individuals, With Howa Yeung, MD, MSc

Topical Antioxidant Serum May Be Effective in Treating Atrophic Acne Scars

Melanoma Surgery Delay After 4 Weeks Post-Diagnosis Decreases Survival Rates

Ritlecitinib Efficacious for Non-Segmental Vitiligo Across Various Subgroups

ICP-332 Effective, Safe for Treating Moderate to Severe Atopic Dermatitis

Unmet Needs Highlighted Regarding CSU Treatment Escalation

Recommended News For You

There is a 40% reduction in the risk of 9 cancers with good cardiorespiratory fitness.

Avoiding Neuropathy From Chemo; Predictive Value of Screening EKGs

Veterans of the Navy have high lung cancer rates associated with asbestos use.

A radiotheranostic approach designed to combat aggressive cancers

Month-Long Wait Times Caused by US Physician Shortage.

Two medications might work better for breast cancers that are resistant to one.

What is a "cancer vaccine" and is it the same as a COVID vaccine?

Whats more on Hidoc Dr.

Medical Updates

KOL Videos

Surveys

Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world

2.

Patients with metastatic breast cancer can predict their response to HER2-targeted therapy using whole-body PET/CT.

3.

The Early Progression of Prostate Cancer Is Not Stopped by Metformin.

4.

Marstacimab Gets FDA Nod for Hemophilia A or B Without Inhibitors

5.

ASCO: Durvalumab plus FLOT beneficial for resectable gastric, GE junction cancer

1.

A Closer Look at Breast Cancer: Examining the Ultrasound Images

2.

Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage

3.

How Digital Innovation and AI-Powered Case Studies are Revolutionizing Oncology Education?

4.

A New Dawn for Triple-Negative Breast Cancer: Emerging Therapies and the Art of Healing

5.

Unveiling the Hidden Benefits of Lymphedema Treatment

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Efficient Management of First line ALK-rearranged NSCLC - Part III

2.

Navigating the Complexities of Ph Negative ALL - Part VII

3.

Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites

4.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Most Squamous Cell Carcinomas are Found in the Head and Neck Region.

Latest News

Upadacitinib Switch from Dupilumab Effective in Head and Neck Atopic Dermatitis

Updated Urticaria Guidelines Clarify Diagnosis, Biomarkers, Treatment Pathways

6 Dermatology Headlines You Missed in January 2026

Bimekizumab Demonstrates Long Term Efficacy in Hidradenitis Suppurativa

Expert Consensus on Knowledge Gaps in Dermatology for Skin of Color, With Henry Lim, MD Henry Lim, MD

Upadacitinib Regulatory Applications Submitted for Adults, Adolescents with Vitiligo

Todays Updates

Phase 3b RESHAPE Study Evaluates Risk–Benefit of Switching From Ocrelizumab to BTK Inhibitor Remibrutinib Isabella Ciccone, MPH

Todays Updates

Phase 3b RESHAPE Study Evaluates Risk–Benefit of Switching From Ocrelizumab to BTK Inhibitor Remibrutinib Isabella Ciccone, MPH

Latest News

News All Time

Practical Approaches to Hyperpigmentation and Hypopigmentation, With Nada Elbuluk, MD, MSc, and Michelle Rodrigues, MBBS Nada Elbuluk, MD, MSc, Michelle Rodrigues, MBBS

Skin of Color Savvy: Highlights from 2025 Tim Smith

Skin of Color Savvy: On-Site Interviews at the Meeting the Challenge Summit Angel S. Byrd, MD, PhD, Valerie D. Callender, MD, Valerie Harvey, MD, MPH, Stafford Brown, MD, MBA

Skin of Color Savvy: Highlights From the Most-Watched Episodes of 2025 Andrew F Alexis, MD, MPH, Shawn Kwatra, MD, Crystal Aguh, MD, FAAD, John E. Harris, MD, PhD, Nada Elbuluk, MD, MSc, Michelle Rodrigues, MBBS

Maui Derm 2026 Presentation Highlights Icotrokinra, Other New Dermatology Drugs

The HCPFive: Top News for Healthcare Providers from the Week of 01/18

Amlitelimab Effective, Safe for Atopic Dermatitis in Patients 12 Years and Older

LEVEL UP: New Data on Switching from Dupilumab to Upadacitinib in Atopic Dermatitis

Personalized Care Improvements Identified for Older Patients with Skin Cancer

What to Expect at the 2026 Maui Derm Conference

New Findings on Acne Incidence in Transgender Individuals, With Howa Yeung, MD, MSc

Topical Antioxidant Serum May Be Effective in Treating Atrophic Acne Scars

Melanoma Surgery Delay After 4 Weeks Post-Diagnosis Decreases Survival Rates

Ritlecitinib Efficacious for Non-Segmental Vitiligo Across Various Subgroups

ICP-332 Effective, Safe for Treating Moderate to Severe Atopic Dermatitis

Unmet Needs Highlighted Regarding CSU Treatment Escalation

Recommended News For You

There is a 40% reduction in the risk of 9 cancers with good cardiorespiratory fitness.

Avoiding Neuropathy From Chemo; Predictive Value of Screening EKGs

Veterans of the Navy have high lung cancer rates associated with asbestos use.

A radiotheranostic approach designed to combat aggressive cancers

Month-Long Wait Times Caused by US Physician Shortage.

Two medications might work better for breast cancers that are resistant to one.

What is a "cancer vaccine" and is it the same as a COVID vaccine?

Recommended Articles For You

The Pivotal Role of Telomerase in Breast Cancer Therapy Resistance and Treatment Strategies

How Should We Approach Solid Pseudopapillary Neoplasm of the Pancreas with Hepatic Metastases?

What are Acanthocytes? Understanding the Role of Spiky Red Blood Cells

Strategic Deals and FDA Approvals Transforming U.S. Oncology Drug Development

Whats more on Hidoc Dr.

Medical Updates

KOL Videos

Surveys

Events

Featured News

Featured Articles

Featured Events

Featured KOL Videos

Quick Links

Verification

Welcome to Hidoc Dr.